UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1952) 1952
science & technology (1464) 1464
life sciences & biomedicine (1363) 1363
animals (1148) 1148
antibody-dependent cell cytotoxicity - drug effects (1098) 1098
antibody-dependent cell cytotoxicity (833) 833
mice (696) 696
female (680) 680
killer cells, natural - immunology (592) 592
immunology (553) 553
oncology (551) 551
male (497) 497
antibody-dependent cell cytotoxicity - immunology (451) 451
cell line, tumor (392) 392
killer cells, natural - drug effects (367) 367
cytotoxicity (345) 345
adult (323) 323
immunotherapy (317) 317
antibodies, monoclonal - pharmacology (310) 310
antibodies, monoclonal - immunology (294) 294
antibodies, monoclonal - therapeutic use (281) 281
monoclonal antibodies (281) 281
middle aged (274) 274
cancer (260) 260
abridged index medicus (240) 240
antibodies (240) 240
adcc (220) 220
cell line (217) 217
cytotoxicity, immunologic - drug effects (217) 217
flow cytometry (211) 211
antineoplastic agents - pharmacology (205) 205
cells, cultured (200) 200
hematology (198) 198
tumor cells, cultured (198) 198
antibody-dependent cell-mediated cytotoxicity (192) 192
rituximab (185) 185
research article (182) 182
aged (180) 180
antibody-dependent cellular cytotoxicity (174) 174
medicine, research & experimental (173) 173
research & experimental medicine (173) 173
lymphocyte activation - drug effects (157) 157
lymphocytes - immunology (156) 156
neoplasms - immunology (156) 156
xenograft model antitumor assays (153) 153
research (148) 148
immunoglobulin g (144) 144
t-lymphocytes - immunology (143) 143
natural killer cells (142) 142
monocytes - immunology (140) 140
immunoglobulin g - immunology (138) 138
mice, inbred balb c (138) 138
tumors (138) 138
macrophages - immunology (135) 135
proteins (135) 135
health aspects (134) 134
neutrophils - immunology (132) 132
toxicity (130) 130
cell biology (128) 128
immunoglobulins (128) 128
rats (126) 126
antigens (125) 125
cytotoxicity, immunologic (123) 123
in vitro techniques (122) 122
analysis (119) 119
viral antibodies (117) 117
dose-response relationship, drug (116) 116
interleukin-2 - pharmacology (116) 116
trastuzumab (116) 116
care and treatment (114) 114
mice, scid (113) 113
antibodies, monoclonal, humanized (112) 112
receptors, igg - immunology (112) 112
antineoplastic agents - therapeutic use (108) 108
killer cells, natural - metabolism (105) 105
time factors (105) 105
apoptosis - drug effects (103) 103
receptors, igg - metabolism (103) 103
monoclonal antibody (101) 101
disease models, animal (100) 100
killer cells (100) 100
biochemistry & molecular biology (98) 98
science & technology - other topics (98) 98
cell proliferation - drug effects (97) 97
multidisciplinary sciences (97) 97
antibodies, monoclonal, humanized - pharmacology (95) 95
lymphocytes (94) 94
apoptosis (93) 93
complement system proteins - immunology (92) 92
antibodies, monoclonal - administration & dosage (91) 91
lymphocytes - drug effects (91) 91
mice, nude (90) 90
phagocytosis - drug effects (89) 89
neutrophils - drug effects (87) 87
phagocytosis (87) 87
antibodies, monoclonal, murine-derived (86) 86
pharmacology & pharmacy (86) 86
mice, inbred c57bl (85) 85
antigens, cd20 - immunology (82) 82
chemical and pharmacologic phenomena (82) 82
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2441) 2441
Japanese (40) 40
German (22) 22
Russian (17) 17
Chinese (12) 12
French (7) 7
Hungarian (4) 4
Spanish (4) 4
Portuguese (3) 3
Bulgarian (2) 2
Italian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 3, pp. 399 - 409
Summary Lenalidomide is an immunomodulatory agent that has demonstrated clinical benefit for patients with relapsed or refractory mantle cell lymphoma (MCL... 
immunomodulation | mantle cell lymphoma | antibody‐dependent cell‐mediated cytotoxicity | lenalidomide | natural killer cell | antibody-dependent cell-mediated cytotoxicity | Life Sciences & Biomedicine | Hematology | Science & Technology | Pyrazoles - therapeutic use | Coculture Techniques | Humans | Tumor Microenvironment | Thalidomide - pharmacology | Dose-Response Relationship, Drug | Thalidomide - analogs & derivatives | Killer Cells, Natural - immunology | Tumor Cells, Cultured | Cytotoxicity, Immunologic - drug effects | Lymphoma, Mantle-Cell - genetics | Lymphoma, Mantle-Cell - metabolism | Peptide Hydrolases - metabolism | Pyrazoles - pharmacology | Lenalidomide | Pyrimidines - administration & dosage | Immunologic Factors - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Pyrimidines - pharmacology | Thalidomide - administration & dosage | Pyrazoles - administration & dosage | Pyrimidines - therapeutic use | Lymphoma, Mantle-Cell - immunology | Lymphocyte Count | Killer Cells, Natural - drug effects | Mutation | Thalidomide - therapeutic use | Immunologic Factors - pharmacology | Immunologic Factors - therapeutic use | Viral antibodies | Tyrosine | Killer cells | Gene mutations | Analysis | Antibodies | Lymphomas | Immunomodulation | Toxicity | Cytotoxicity | Immunological synapses | Kinases | Survival | Patients | Lymphoma | Granzyme B | Immunology | Lymphocytes | Mantle cell lymphoma | Natural killer cells | Mantle | Protein-tyrosine kinase | Tumors | Index Medicus
Journal Article
British journal of haematology, ISSN 1365-2141, 02/2019, Volume 185, Issue 2, pp. 240 - 253
...‐dependent cellular cytotoxicity in sensitive and chemo‐resistant FL cells, via a cereblon... 
immunomodulation | non‐Hodgkin lymphoma | antibody‐dependent cell‐mediated cytotoxicity | lenalidomide | follicular lymphoma | non-Hodgkin lymphoma | antibody-dependent cell-mediated cytotoxicity | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Immunotherapy - methods | Lymphoma, Follicular - drug therapy | Humans | Antibody-Dependent Cell Cytotoxicity - immunology | Cyclophosphamide - therapeutic use | Rituximab - therapeutic use | Lymphocyte Activation - immunology | Killer Cells, Natural - immunology | Tumor Cells, Cultured | Neutrophils - drug effects | Drug Resistance, Neoplasm - immunology | Rituximab - administration & dosage | B-Lymphocytes - drug effects | Lenalidomide - administration & dosage | Immunological Synapses - drug effects | Lenalidomide - immunology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphocyte Activation - drug effects | CD8-Positive T-Lymphocytes - drug effects | Immunological Synapses - immunology | Vincristine - therapeutic use | Lymphocyte Count | Cell Proliferation - drug effects | Killer Cells, Natural - drug effects | Rituximab - immunology | Antibody-Dependent Cell Cytotoxicity - drug effects | CD8-Positive T-Lymphocytes - immunology | Cytokines - biosynthesis | Prednisone - therapeutic use | Antimitotic agents | Viral antibodies | Killer cells | Chemotherapy | Cell death | Analysis | Immunotherapy | Antibodies | Lymphomas | Biochemistry | Antineoplastic agents | Cancer | Toxicity | Rituximab | Cytotoxicity | Immunological synapses | Lymphocytes T | Lymphoma | Immunity | Patients | Immunosuppression | Immunology | Natural killer cells | Synapses | Tumors | Neutropenia | Index Medicus | Life Sciences | Human health and pathology | Haematological Malignancy | Research Paper
Journal Article
Molecular cancer therapeutics, ISSN 1538-8514, 04/2015, Volume 14, Issue 6, pp. 1414 - 1423
Journal Article
Immunologic research, ISSN 1559-0755, 12/2015, Volume 64, Issue 2, pp. 548 - 557
Journal Article